On 3 October 2016, Taylor Wessing’s International Life Sciences Group launched The Treatment – A guide for life sciences companies coming to Europe. This unique publication is designed to provide a high level overview of the most important issues that should be considered for any life sciences company wishing to do business in Europe. It represents a distillation of our International Life Sciences Group's many years of experience in helping life sciences companies to do business in Europe and to thrive there.
A legal toolkit for life sciences companies and their investors providing access to information on:
Tasmina Goraya discusses Advocate General Sharpston's Opinion to the Court of Justice of the European Union on the liability and obligations of Notified Bodies under the Medical Devices Directive in Elisabeth Schmitt v TÜV Rheinland LGA Products GmbH. read more
Paul England examines the potential impacts of Brexit on SPCs, paediatric extensions to SPCs and market exclusivity for orphan medicinal products. read more
Saufung Ma discusses the recent decision of the CJEU in F. Hoffman-La Roche AG v Accord Healthcare OÜ and its impact upon the calculation of Supplementary Protection Certificate term in accession countries.read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...